Pharmacotherapeutic follow-up in patients with type 1 diabetes in context of judicialization: possibility optimize costs. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 59, p. e23264, 2023. DOI: 10.1590/s2175-97902023e23264. Disponível em: https://journals.usp.br/bjps/article/view/227843.. Acesso em: 9 apr. 2025.